Ro vs Wisp
Wisp costs $50 less a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Ro
Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC
Visit Ro →
If you are choosing between Ro and Wisp, the first difference is cost: Wisp is $50 a month cheaper at the entry price. Ro leads our six-part score, 6.7 to 6.5.
Ro vs Wisp price
Wisp is the cheaper way in: $99 a month against $149 a month at Ro. That is $50 less each month (34% lower), or about $600 over a year of treatment.
Medications and formats
Ro and Wisp do not overlap on medication; only Ro lists orforglipron; only Wisp lists semaglutide and tirzepatide.
On format, Ro prices brand-name pens, while Wisp prices compounded injections and brand-name pens.
Where each one treats patients
Neither Ro nor Wisp publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Ro
Additional membership fees apply
Wisp
Monthly subscription supplement, NOT a prescription GLP-1 medication. 'subscription' in form keeps it out of the GLP-1 hero price. drug omitted intentionally.
Zepbound $99/mo (compounded sublingual semaglutide $225/mo)
What each price covers
Ro's price also covers the clinician visit, lab work and coaching, which Wisp does not claim.
Wisp's price also covers the medication itself and shipping, which Ro does not claim.
Ro is silent on shipping.
Wisp is silent on the clinician visit, lab work and coaching.
That matters most for the drug: unless Ro confirms otherwise, budget for medication on top of its listed price.
Ro
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Wisp
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Ro scores 6.7 and Wisp 6.5 out of 10.
Ro is stronger on value (5.0 vs 3.5), trust & safety (8.0 vs 6.5) and support (5.5 vs 4.5).
Wisp is stronger on effectiveness (10.0 vs 8.0).
User experience and accessibility are within half a point.
Ro
6.7/10
Wisp
6.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Ro nor Wisp has an FDA warning letter on record with us.
Features & Coverage
| Feature | Ro | Wisp |
|---|---|---|
| Starting Price | $149/mo | ✓$99/mo |
| Features | 7 features | ✓8 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Ro
Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.
Read our full Ro review →About Wisp
$225/month buys a compounded sublingual semaglutide drops formulation from Wisp. Its weight care vertical also stocks three brand names: Saxenda, Zepbound, and Wegovy. A board-certified provider completes the review inside 24-72 hours. LegitScript certification is in place.
Read our full Wisp review →Pros & Cons
Ro
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits, lab work and coaching
- Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Ro
Watch-outs
- Not included in the monthly price: medication
- Confirm it serves your state before you start the intake
Wisp
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and shipping
- We found no FDA warning letters issued to Wisp
Watch-outs
- Semaglutide costs $225 a month, 22% above the $184 median for compounded semaglutide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Ro wins this one, 6.7 to 6.5, above all for knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC. Wisp undercuts it by $50 a month, so if the monthly bill is what decides it, Wisp is the pick. Wisp fits better if an oral route if you will not self-inject is your priority.
Choose Ro if…
You want knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC and an opening price near $149 a month.
Choose Wisp if…
You want an oral route if you will not self-inject and an opening price near $99 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Ro vs Wisp: FAQ
Close alternatives to Ro and Wisp
- Ro vs Amazon One Medical
- Ro vs LillyDirect Foundayo
- Ro vs GoodRx
- Ro vs Found
- Wisp vs GobyMeds
- Wisp vs HeliMeds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.